CL2017001320A1 - Nuevos compuestos hidrosolubles derivados del bencimidazol, - Google Patents

Nuevos compuestos hidrosolubles derivados del bencimidazol,

Info

Publication number
CL2017001320A1
CL2017001320A1 CL2017001320A CL2017001320A CL2017001320A1 CL 2017001320 A1 CL2017001320 A1 CL 2017001320A1 CL 2017001320 A CL2017001320 A CL 2017001320A CL 2017001320 A CL2017001320 A CL 2017001320A CL 2017001320 A1 CL2017001320 A1 CL 2017001320A1
Authority
CL
Chile
Prior art keywords
compounds derived
benzimidazole
soluble compounds
new water
independently
Prior art date
Application number
CL2017001320A
Other languages
English (en)
Inventor
Bocanegra Rafael Castillo
Ramos Miguel Angel Flores
Campos Maria Alicia Hernandez
Velarde Osvaldo Froylan Ibarra
Montenegro Remedios Yolanda Vera
Original Assignee
Univ Mexico Nac Autonoma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=56074744&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CL2017001320(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Univ Mexico Nac Autonoma filed Critical Univ Mexico Nac Autonoma
Publication of CL2017001320A1 publication Critical patent/CL2017001320A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D235/28—Sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/06—Phosphorus compounds without P—C bonds
    • C07F9/08—Esters of oxyacids of phosphorus
    • C07F9/09—Esters of phosphoric acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/645—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having two nitrogen atoms as the only ring hetero atoms
    • C07F9/6503—Five-membered rings
    • C07F9/6506—Five-membered rings having the nitrogen atoms in positions 1 and 3
    • C07F9/65068—Five-membered rings having the nitrogen atoms in positions 1 and 3 condensed with carbocyclic rings or carbocyclic ring systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

<p>COMPUESTOS HIDROSOLUBLES DERIVADOS DEL BENCIMIDAZOL REPRESENTADOS POR LA FORMULA GENERAL I, EN DONDE Y1 E Y2 SON INDEPENDIENTEMENTE O O S. Y PAR LO MENOS UNO DE Y1E Y2 ES O; R1Y R2 SON INDEPENDIENTEMENTE HIDRÓGENO O UN CATIÓN, AMBOS SON HIDROGENO O AMBOS SON CATIONES; R3 ES UN ALQUILO QUE TIENE DE 1 A 4 ÁTOMOS DE CARBONO; R4Y R5SON INDEPENDIENTEMENTE HALÓGENO O  UN ALCÓXIDO —OR6 : R6 ES ARILO DE 6 A 10 ÁTOMOS DE CARBONO UNIDOS EN LA POSICIÓN 5- O 6- DEL NÚCLEO DE BENCIMIDAZOL.</p>
CL2017001320A 2014-11-26 2017-05-23 Nuevos compuestos hidrosolubles derivados del bencimidazol, CL2017001320A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MX2014014417A MX365051B (es) 2014-11-26 2014-11-26 Nuevos compuestos hidrosolubles derivados del bencimidazol, utiles para el tratamiento de la fasciolosis.

Publications (1)

Publication Number Publication Date
CL2017001320A1 true CL2017001320A1 (es) 2017-12-29

Family

ID=56074744

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2017001320A CL2017001320A1 (es) 2014-11-26 2017-05-23 Nuevos compuestos hidrosolubles derivados del bencimidazol,

Country Status (7)

Country Link
US (1) US10239842B2 (es)
BR (1) BR112017010938B1 (es)
CL (1) CL2017001320A1 (es)
CO (1) CO2017005118A2 (es)
MX (1) MX365051B (es)
PE (1) PE20171112A1 (es)
WO (1) WO2016085319A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108003188A (zh) * 2017-12-25 2018-05-08 长春吉大天元化学技术股份有限公司 一种烷基磷酸酯类化合物的新型纯化方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9103776D0 (sv) 1991-12-19 1991-12-19 Astra Ab New compounds
ES2344275T3 (es) 2005-07-28 2010-08-23 Intervet International Bv Nuevos (tio) carbamatos de benzimidazol con actividad antiparasitaria y sintesis de ellos.

Also Published As

Publication number Publication date
CO2017005118A2 (es) 2017-09-20
PE20171112A1 (es) 2017-08-07
BR112017010938B1 (pt) 2022-08-16
BR112017010938A2 (pt) 2018-07-03
US10239842B2 (en) 2019-03-26
MX2014014417A (es) 2016-05-26
US20170327470A1 (en) 2017-11-16
MX365051B (es) 2019-05-09
WO2016085319A1 (es) 2016-06-02

Similar Documents

Publication Publication Date Title
EA201600091A1 (ru) 4-членные кольцевые карбоксамиды, применяемые в качестве нематоцидов
NI201800075A (es) Derivados de tiohidantoína sustituidos como antagonistas del receptor de andrógenos.
CR20150509A (es) Derivados de naftiridina utiles como antagonistas de la alfa-v-beta-6 integrina
EA201892147A1 (ru) Бициклические соединения
EA201692219A1 (ru) Способы получения противовирусных соединений
EA201401054A1 (ru) N-циклиламиды в качестве нематоцидов
CR20160418A (es) Nuevos compuestos biciclicos de 7 eslabones
CL2019001381A1 (es) Método para el tratamiento de glomeruloesclerosis segmentaria focal.
CL2016001349A1 (es) Uso de derivados de bencimidazol-prolina
MX2017006269A (es) Sistemas y metodos de control adecuados para el uso con sistemas y metodos de produccion de energia.
MX2019011256A (es) Concentrados anticongelantes anticorrosivos.
CR20170005A (es) Derivados de insoindolina
BR112017013286A2 (pt) composto de isoxazolina, e, uso de um composto de isoxazolina.
PH12015502665A1 (en) Improvements in or relating to organic compounds
CL2016000038A1 (es) Piraxolo-piridinaminas sustituidas
CL2016001623A1 (es) Compuestos de benzamida y nicotinamida y métodos para usar los mismos.
AR103317A1 (es) Moduladores de ciclopropil dihidrobenzofurano de receptores de melatonina
CL2017000151A1 (es) Derivados de piridona
GEAP201814266A (en) Pyrazines modulators of gpr6
DOP2015000176A (es) Compuestos de azetidiniloxifenilpirrolidina
MX2017002015A (es) Ligando del receptor 2 de canabinoide radiomarcado.
CY1121116T1 (el) Νεα μεθοδος για την συνθεση αγομελατινης
BR112016027455A2 (pt) moduladores ppar
MX381489B (es) Compuesto biciclico y uso del mismo para la inhibicion de suv39h2.
PH12019500479A1 (en) Compositions for treating dementia